Choroideremia
|
0.060 |
Biomarker
|
disease |
BEFREE |
Choroideremia-like (CHML) protein is essential for the prenylation modification of various Rab proteins and it exerts biological effects on vesicle trafficking and signal transduction.
|
31762814 |
2019 |
Choroideremia
|
0.060 |
Biomarker
|
disease |
BEFREE |
Interestingly, the ZIKV infection signature revealed the downregulation of ALDH5A1 and CHML, genes implicated in neurological (cognitive impairment, expressive language deficit, and mild ataxia) and ophthalmic (choroideremia) disorders, respectively.
|
30046058 |
2018 |
Choroideremia
|
0.060 |
Biomarker
|
disease |
BEFREE |
Using semisynthetic fluorescent Rab27A, we demonstrate that although Rab27A can be prenylated by REP-2, this reaction can be effectively inhibited by other Rab proteins, providing a possible explanation for the accumulation of unprenylated Rab27A in choroideremia.
|
15186776 |
2004 |
Choroideremia
|
0.060 |
Biomarker
|
disease |
BEFREE |
The CHM gene encodes a protein of 653 amino acids, which is highly homologous to the mouse and rat CHM proteins, and, to a slightly lesser extent, to the human CHM-like (CHML) protein.
|
7981670 |
1994 |
Choroideremia
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Mapping of the choroideremia-like (CHML) gene at 1q42-qter and mutation analysis in patients with Usher syndrome type II.
|
8188272 |
1994 |
Choroideremia
|
0.060 |
Biomarker
|
disease |
BEFREE |
REP-2, a Rab escort protein encoded by the choroideremia-like gene.
|
8294464 |
1994 |
Zika Virus Infection
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, the ZIKV infection signature revealed the downregulation of ALDH5A1 and CHML, genes implicated in neurological (cognitive impairment, expressive language deficit, and mild ataxia) and ophthalmic (choroideremia) disorders, respectively.
|
30046058 |
2018 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
Interestingly, the ZIKV infection signature revealed the downregulation of ALDH5A1 and CHML, genes implicated in neurological (cognitive impairment, expressive language deficit, and mild ataxia) and ophthalmic (choroideremia) disorders, respectively.
|
30046058 |
2018 |
Biotinidase Deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Corrigendum to "First contiguous gene deletion causing biotinidase deficiency: The enzyme deficiency in three Sri Lankan children" [Mol. Genet. Metab. Rep. 2 (2016) 81-84].
|
28653700 |
2017 |
Spinal Muscular Atrophy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, the CHML and ARHGAP22 genes are associated with the activity of Rab and Rho GTPases, which are important regulators of vesicle formation, actin dynamics, axonogenesis, processes that could be critical for SMA development.
|
23299920 |
2013 |
Coinfection
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Here we report rAAV production by rHSV coinfection of baby hamster kidney (BHK) cells grown in suspension (sBHK cells), using two ICP27-deficient rHSV vectors, one harboring a transgene flanked by the AAV2 inverted terminal repeats and a second bearing the AAV rep2 and capX genes (where X is any rAAV serotype).
|
19419276 |
2009 |
Asthma
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
OPN3 and CHML are unique genes with no known function that are related to the pathophysiology of asthma.
|
18344558 |
2008 |
Asthma
|
0.010 |
Biomarker
|
disease |
BEFREE |
OPN3 and CHML are unique genes with no known function that are related to the pathophysiology of asthma.
|
18344558 |
2008 |
Allergic asthma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Further screening using the pedigree-based association test (PBAT) identified polymorphisms in the OPN3 and CHML genes as being associated with asthma and atopic asthma after correcting for multiple comparisons.
|
18344558 |
2008 |
IgE-mediated allergic asthma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Further screening using the pedigree-based association test (PBAT) identified polymorphisms in the OPN3 and CHML genes as being associated with asthma and atopic asthma after correcting for multiple comparisons.
|
18344558 |
2008 |
Usher syndrome type 2
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate a possible role of the CHML gene in the pathogenesis of USH2, we investigated 10 Dutch and 9 Danish USH2 patients for point mutations in the open reading frame of the CHML gene.
|
8188272 |
1994 |
Blindness
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In the retina, REP-2 may be only partially effective, leading eventually to retinal degeneration and blindness.
|
8294464 |
1994 |
Usher Syndrome, Type II
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mapping of the choroideremia-like (CHML) gene at 1q42-qter and mutation analysis in patients with Usher syndrome type II.
|
8188272 |
1994 |